Scientists say they’ve zeroed in on a cause of Alzheimer’s
By
Alicia Lasek
Dec 03, 2021
Researchers from the University of California, Riverside say they have uncovered a reason why some people with plaques and tangles in their brains do not develop Alzheimer’s disease.
Better dialogue, COVID practices can help reduce stress between family caregivers, providers: study
By
Alicia Lasek
Dec 03, 2021
A new survey offers plenty of ideas for getting long-term care providers on the same page as family caregivers during the COVID-19 pandemic, investigators say.
Biden’s winter COVID plan highlights boosters for seniors, expands access to antibody treatment
By
Alicia Lasek
Dec 03, 2021
The multi-pronged plan, unveiled Thursday, is aimed at further encouraging vaccinations and booster shots — especially among older adults — along with increasing the availability of other tools to...
Clinical briefs for Friday, Dec. 3
By
Alicia Lasek
Dec 03, 2021
First deadline Wednesday for McKnight’s Women of Distinction award nominations … Moderna’s shot comes out on top in first head-to-head vaccine comparison study … Risk of overactive bladder...
Two years into pandemic, we’re better prepared to fight off virus variants
By
Alicia Lasek
Dec 02, 2021
Despite the threat of the quickly spreading and highly mutated omicron coronavirus variant — which has just landed in the U.S. — we are safer than we were before the pandemic, some experts say.
Yearly flu vaccination does not affect SNF resident mortality in large Medicare study
By
Alicia Lasek
Dec 02, 2021
A study of 26 million Medicare recipients has linked regular flu shots with lowered mortality — except in skilled nursing facility residents. The results suggest that vaccines alone are not enough to...
Clinical briefs for Thursday, Dec. 2
By
Alicia Lasek
Dec 02, 2021
Potentially unnecessary prostate cancer screening rate higher in oldest males after USPSTF guidelines reversal … Labor Department extends comment period for OSHA vaccinate-or-test mandate … Short-lived...
FDA advisers endorse Merck’s COVID pill, pending a better option
By
Alicia Lasek
Dec 01, 2021
Molnupiravir, an oral antiviral pill for treating COVID-19, is in line for authorization by the FDA. The Tuesday vote recommending that it be prescribed to U.S. adults was a close one.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
Program pairs nursing students with long-term care facilities to address staffing crisis
By
Alicia Lasek
Dec 01, 2021
Long-term care providers EmpRes Healthcare and Pennant Healthcare are partners in the state-funded externship program with the University of Washington School of Nursing.